Eisai invests in manufacturing capacity
Japanese drugmaker Eisai is planning to double the production capacity for its two top-selling drugs - Pariet and Aricept - by 2004, with an investment of ¥9 billion (€65m).
Archives for June 2, 2003
Merck extends licence to Crucell's cell platform
Dutch firm Crucell has expanded its licensing agreement with US drug major Merck & Co relating to PER.C6, the former's proprietary cell technology platform used for the production of biopharmaceutical products.
AstraZeneca takes on TB in India
AstraZeneca has opened a new multi-million dollar research facility in Bangalore, India, which will focus principally on finding new treatments for tuberculosis, a disease which is diagnosed in about 8 million people worldwide each year.
EU hangs back from mandatory EMEA filings
The European Union's Employment, Social Policy, Health and Consumer Affairs Council agreed on 2 June not to press ahead with proposals to implement a mandatory centralised marketing authorisation scheme for all medicines.
Clariant appoints Italian pharma chief
Aldo Magnini has been appointed managing director of Clariant's pharmaceuticals ingredients manufacturing business in Italy, based around the company's two manufacturing plants in Origgio and Isso.
Diosynth to make Somavert API for Pfizer
Akzo Nobel's Diosynth unit has signed a multi-year contract to manufacture and supply the active pharmaceutical ingredient for Pfizer's growth hormone receptor antagonist Somavert. The value of the agreement was not disclosed, but Akzo claims it will...